Fuji Pharma Co Ltd (4554)-Pharmaceuticals & Healthcare-Deals and Alliances Profile
March 2018
21
About the Report
About the Report
Summary
Fuji Pharma Co Ltd (Fuji Pharma) focuses on development, manufacture, and marketing of pharmaceutical products such as injection agents, internal drugs, drugs for external use and diagnostic products. The company offers medical care products for women, in vitro diagnostics, acute medical care products and curative medicine, and information regarding pharmaceuticals and health. It also conducts research and development programs to discover new drugs. Fuji Pharma offers contract manufacturing services. The company also distributes branded generic drugs with marketing approval from other companies. It operates a manufacturing plant, research and development facility in Toyama. Fuji Pharma is headquartered in Tokyo, Japan.
Fuji Pharma Co Ltd (4554)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents
List of Tables
List of Figures
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Fuji Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deal Details
Partnerships
Fuji Pharma Enters into Distribution Agreement with Mallinckrodt
Licensing Agreements
Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta
Acquisition
Fuji Pharma Completes Acquisition Of Olic For USD53 Million
Fuji Pharma Co Ltd-Key Competitors
Fuji Pharma Co Ltd-Key Employees
Fuji Pharma Co Ltd-Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Financial Announcements
Aug 08, 2017: Fuji Pharma Reports Consolidated Financial Results for the Third Quarter of the Fiscal Year Ending September 30, 2017
May 10, 2017: Fuji Pharma Reports Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending September 30, 2017
Feb 08, 2017: Fuji Pharma Reports Consolidated Financial Results for the First Quarter of the Fiscal Year Ending September 30, 2017
Corporate Communications
Mar 03, 2017: Mithra signs agreement with Fuji Pharma to commercialise Donesta
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Figure
List of Figures
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018
Fuji Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018
List of Table
List of Tables
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
Fuji Pharma Co Ltd, Deals By Therapy Area, 2012 to YTD 2018
Fuji Pharma Co Ltd, Medical Devices Deals, 2012 to YTD 2018
Fuji Pharma Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
Fuji Pharma Enters into Distribution Agreement with Mallinckrodt
Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta
Fuji Pharma Completes Acquisition Of Olic For USD53 Million
Fuji Pharma Co Ltd, Key Competitors
Fuji Pharma Co Ltd, Key Employees
Fuji Pharma Co Ltd, Subsidiaries
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.